Zhelong Li
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology
- Cardiology and Cardiovascular Medicine top 10%
- Biomedical Engineering
- Topics
- Extracellular vesicles in disease (18 papers)RNA Interference and Gene Delivery (6 papers)MicroRNA in disease regulation (6 papers)
- Partner nations
- China
In The Last Decade
Zhelong Li
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 1.1k
- Cancer Research 571
- Immunology 213
- Cardiology and Cardiovascular Medicine 187
- Biomedical Engineering 166
Countries citing papers authored by Zhelong Li
This map shows the geographic impact of Zhelong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhelong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhelong Li more than expected).
Fields of papers citing papers by Zhelong Li
This network shows the impact of papers produced by Zhelong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhelong Li. The network helps show where Zhelong Li may publish in the future.
Co-authorship network of co-authors of Zhelong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Zhelong Li. A scholar is included among the top collaborators of Zhelong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhelong Li. Zhelong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 21 | |
| 3 | 8 | |
| 4 | 16 | |
| 5 | 15 | |
| 6 | 27 | |
| 7 | 0 | |
| 8 | 10 | |
| 9 | 19 | |
| 10 | 62 | |
| 11 | 8 | |
| 12 | 135 | |
| 13 | 100 | |
| 14 | 14 | |
| 15 | 18 | |
| 16 | 77 | |
| 17 | 37 | |
| 18 | 118 | |
| 19 | 75 | |
| 20 | 73 |
About Zhelong Li
Zhelong Li is a scholar working on Cancer Research, Immunology and Cardiology and Cardiovascular Medicine, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (18 papers), RNA Interference and Gene Delivery (6 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (571 citations), Molecular Biology (1.1k citations) and Immunology (213 citations). Zhelong Li has collaborated with scholars based in China. Frequent co-authors include Lijun Yuan, Guodong Yang, Wenqi Sun, Mengying Wei, Xueying Zhou, Lianbi Zhao, Yunnan Liu, Xiaotong Gao, Chen Wang and Zhuo Wan. Their work appears in journals such as Nature Communications, Nano Letters and Environmental Science & Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.